Q32 Bio Inc (NASDAQ:QTTB) price on Wednesday, April 30, rose 2.89% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.60.
A look at the stock’s price movement, the close in the last trading session was $1.55, moving within a range at $1.43 and $1.65. Turning to its 52-week performance, $53.79 and $1.38 were the 52-week high and 52-week low respectively. Overall, QTTB moved -3.03% over the past month.
Q32 Bio Inc’s market cap currently stands at around $19.52 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-10.
Turning to the stock’s technical picture we see that short term indicators suggest on average that QTTB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend QTTB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
QTTB’s current price about -9.76% and -19.35% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.22, while 7-day volatility ratio is 12.23% and 14.17% in the 30-day chart. Further, Q32 Bio Inc (QTTB) has a beta value of -0.01, and an average true range (ATR) of 0.22. Analysts have given the company’s stock an average 52-week price target of $64, forecast between a low of $64 and high of $64. Looking at the price targets, the low is -3900.0% off current price level while to achieve the yearly target high, price needs to move -3900.0%. Nonetheless, investors will most likely welcome a -3900.0% jump to $64 which is the analysts’ median price.
If we refocus on Q32 Bio Inc (NASDAQ:QTTB), historical trading data shows that trading volumes averaged 0.26 over the past 10 days and 208.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 12.20 million shares.
The 63.73% of Q32 Bio Inc’s shares are in the hands of company insiders while institutional holders own 30.01% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.87 million on 2025-04-15, giving us a short ratio of 4.11. Current price change has pushed the stock -53.49% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the QTTB stock continues to rise going into the next quarter.
